Improving HPV vaccination rates among adolescents.
Official title: TweenVax: A comprehensive practice-, provider-, and parent/patient-level intervention to improve adolescent HPV vaccination.
Funded at Emory University · NIH-10799134 · Data updated 2026-11-12
This study is all about helping more kids aged 11 to 12 get the HPV vaccine by improving how doctors talk about it and teaching parents why it's important, so they can feel more supported in getting their children vaccinated.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $484,036 |
| NIH project number | 4R37CA234119-06 |
| Project ID | NIH-10799134 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents aged 11 to 12 years who are due for their HPV vaccination.
✕Less likely to help
Patients who have already completed the HPV vaccination series or are older than 13 years may not benefit from this research.
What this research studies
This research focuses on increasing the rates of HPV vaccination among adolescents aged 11 to 12 years by implementing a comprehensive intervention called TweenVax. The approach involves enhancing communication and recommendations from healthcare providers, as well as educating parents and patients about the importance of the HPV vaccine. By addressing barriers to vaccination through a systems-level strategy, the study aims to create a supportive environment that encourages vaccination. The intervention will be evaluated through a randomized trial to assess its effectiveness in improving vaccination rates.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers in adolescents.
How similar studies have gone: Previous research has shown that targeted interventions can effectively improve vaccination rates, suggesting that this approach may also yield positive results.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Bednarczyk, Robert a. — Emory University
- Study coordinator: Bednarczyk, Robert a.
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.